Table 1.
The Relationship between miR-532-3p and Clinicopathological Characteristics in 142 Patients with Prostate Cancer
Parameters | No. of Cases | miR-532-3p Expression |
p Values | |
---|---|---|---|---|
Low | High | |||
Age (years) | ||||
≤71 | 72 | 37 | 35 | 0.737 |
>71 | 70 | 34 | 36 | |
Differentiation | ||||
Well/moderate | 65 | 31 | 34 | 0.613 |
Poor | 77 | 40 | 37 | |
Serum PSA | ||||
<23.6 | 66 | 32 | 34 | |
>23.6 | 76 | 39 | 37 | 0.043∗ |
Gleason grade | ||||
≤7 | 81 | 31 | 50 | |
>7 | 61 | 40 | 21 | <0.001∗ |
BM status | ||||
BM-free | 103 | 44 | 59 | |
BM | 39 | 27 | 12 | 0.005∗ |
PSA, prostate-specific antigen; BM, bone metastasis. ∗p < 0.05.